PHENOBARBITAL SODIUM INJECTION, USP 120 MG — DIN 02304090
PHENOBARBITAL SODIUM : 120 MG · SANDOZ CANADA INCORPORATED · SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is PHENOBARBITAL SODIUM INJECTION, USP?
PHENOBARBITAL SODIUM INJECTION, USP 120 MG contains PHENOBARBITAL SODIUM : 120 MG. It is listed in the Health Canada Drug Product Database under DIN 02304090, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 29-Feb-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PHENOBARBITAL SODIUM INJECTION, USP used for?
Control of generalized tonic-clonic and complex partial seizures; management of status epilepticus or acute seizure episodes.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Phenobarbital cost around the world?
Phenobarbital is listed on 10 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Czechia publishes a max producer price (ex-factory); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 10 | 130 | USD███.██ |
| Iceland | max wholesale | 4 | 8 | ISK███.██ |
| United Kingdom | hospital | 7 | 7 | GBP███.██ |
| South Africa | single exit price | 3 | 4 | ZAR███.██ |
| Australia | ex-manufacturer | 3 | 3 | AUD███.██ |
| Czechia | max producer price (ex-factory) | 3 | 3 | CZK███.██ |
| Morocco | PPV (public price) | 1 | 3 | MAD███.██ |
| Romania | max producer price | 3 | 3 | RON███.██ |
| Greece | producer price (ex-factory) | 1 | 1 | EUR███.██ |
| Luxembourg | reimbursement | 1 | 1 | EUR███.██ |
163 pack listings across 36 brand entries and 10 price bases, refreshed 08 Sep 2026. Ranges span every Phenobarbital pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Phenobarbital in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Phenobarbital, across 30 DINs, of which 11 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 5 | 5 | PHENOBARB, PHENOBARB ELIXIR | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 4 | 4 | JAMP PHENOBARBITAL | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 2 | 2 | PHENOBARBITAL SODIUM INJECTION, USP | Sourceable in Canada |
| D.C. LABS LIMITED | 5 | 0 | BARBILIXIR ELX 4MG/ML, PHENOBARBITAL TABLET 100MG, PHENOBARBITAL TABLET 15MG, PHENOBARBITAL TABLET 30MG, PHENOBARBITAL TABLET 60MG | No marketed DIN |
| PHARMASCIENCE INC | 5 | 0 | PMS-PHENOBARBITAL, PMS-PHENOBARBITAL ELIXIR | No marketed DIN |
| ERFA CANADA 2012 INC | 3 | 0 | PHENOBARBITAL TAB 15MG, PHENOBARBITAL TAB 30MG, PHENOBARBITAL TAB 60MG | No marketed DIN |
| VALEANT CANADA LP / VALEANT CANADA S.E.C. | 3 | 0 | PHENOBARBITAL TAB 15MG, PHENOBARBITAL TAB 30MG, PHENOBARBITAL TAB 60MG | No marketed DIN |
| HOSPIRA HEALTHCARE ULC | 1 | 0 | PHENOBARBITAL SODIUM INJECTION 120MG/ML | No marketed DIN |
| HOSPIRA HEALTHCARE ULC 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5 | 1 | 0 | PHENOBARBITAL SODIUM INJECTION 30MG/ML | No marketed DIN |
| VALEANT CANADA LP / VALEANT CANADA S.E.C. 2150 Boul. St-Elzear Ouest Laval Quebec Canada H7L 4A8 | 1 | 0 | PHENOBARBITAL 100MG TAB | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 120 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR ; INTRAVENOUS |
| Pack configuration (monograph) | Boxes of 10 ampoules of 1 mL each. |
| Storage | Store between 15°C and 25°C. Protect from freezing. Protect from light. Do not use if precipitate present. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Phenobarbital |
|---|---|
| ATC code | N03AA02 |
| AHFS class | 28:12.04 ; 28:24.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02304090 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2304090 |
| Brand name | PHENOBARBITAL SODIUM INJECTION, USP |
| Generic / active ingredient | PHENOBARBITAL SODIUM : 120 MG |
| Market authorization holder | SANDOZ CANADA INCORPORATED |
| Health Canada schedule | CONTROLLED DRUGS (CDSA IV) |
| ATC code | N03AA02 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N03AA |
| Current status | MARKETED |
| Status date | 29-Feb-2008 |
| Original market date | 2008-02-29 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Deep IM or slow IV injection. Adults: 100-320 mg IV for anticonvulsant; 20 mg/kg IV for status epilepticus. Max 2 g daily. Slow administration is essential to prevent cardiovascular collapse.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to barbiturates; porphyria; severe respiratory depression; renal/hepatic impairment; sleep apnea; suicidal potential; alcoholism; drug dependence; uncontrolled pain; newborns.
Warnings and precautions
Potential for psychological/physiologic dependence. Risk of suicidal ideation. Serious skin reactions (SJS/TEN). Avoid rapid IV injection (risk of apnea/collapse). Risk of decreased bone density.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
11 of 30 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP PHENOBARBITAL | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02557819 |
| JAMP PHENOBARBITAL | 15 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02557789 |
| JAMP PHENOBARBITAL | 30 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02557797 |
| JAMP PHENOBARBITAL | 60 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02557800 |
| PHENOBARB | 100 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | 00178829 |
| PHENOBARB | 60 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | 00178810 |
| PHENOBARB | 30 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | 00178802 |
| PHENOBARB | 15 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | 00178799 |
| PHENOBARB ELIXIR | 5 MG | SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | 00645575 |
| PHENOBARBITAL SODIUM INJECTION, USP | 30 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02304082 |
2 · Same class — other molecules in ATC N03AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Phenobarbital | BARBILIXIR ELX 4MG/ML · JAMP PHENOBARBITAL · PHENOBARB · PHENOBARB ELIXIR · PHENOBARBITAL 100MG TAB · PHENOBARBITAL SODIUM INJECTION 120MG/ML · PHENOBARBITAL SODIUM INJECTION 30MG/ML · PHENOBARBITAL SODIUM INJECTION, USP · PHENOBARBITAL TAB 15MG · PHENOBARBITAL TAB 30MG · PHENOBARBITAL TAB 60MG · PHENOBARBITAL TABLET 100MG · PHENOBARBITAL TABLET 15MG · PHENOBARBITAL TABLET 30MG · PHENOBARBITAL TABLET 60MG · PMS-PHENOBARBITAL · PMS-PHENOBARBITAL ELIXIR | 30 | 11 | Yes |
| Primidone | MYSOLINE 250MG TAB · MYSOLINE PEDIATRIC CHEWABLE TABLETS 125MG · MYSOLINE TAB 125MG · PRIMIDONE · PRIMIDONE 125 TAB · PRIMIDONE 250 TAB · SERTAN TAB 125MG · SERTAN TAB 250MG | 9 | 2 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N03A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N03AX | Brivaracetam · Cannabidiol · Cenobamate · Lacosamide · Lamotrigine · Levetiracetam · Perampanel · Stiripentol · Topiramate | 391 | 197 |
| N03AF | Carbamazepine · Eslicarbazepine · Oxcarbazepine · Rufinamide | 86 | 33 |
| N03AG | Valproic Acid · Vigabatrin | 75 | 19 |
| N03AB | Fosphenytoin · Phenytoin · Phenytoin, Combinations | 17 | 8 |
| N03AE | Clonazepam | 55 | 8 |
| N03AD | Ethosuximide · Mesuximide | 5 | 4 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PHENOBARBITAL SODIUM INJECTION, USP called?
The same molecule, Phenobarbital, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| GARDENAL | Latin | Morocco |
| Aphenylbarbit | Latin | Iceland |
| Phenoleptil | Latin | Iceland |
| Sedabarb | Latin | South Africa |
| Donnatal Elixir | Latin | South Africa |
| Lethyl | Latin | South Africa |
| LUMINAL | Latin | Czechia |
| PHENAEMAL | Latin | Czechia |
| PHENAEMALETTEN | Latin | Czechia |
| Phenobarb | Latin | Australia |
| Phenobarbital | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.